原发性肝癌（primary carcinoma of liver）是我国最常见的恶性肿瘤之一，其起病隐匿，恶性程度高，患者发病时大多已属中晚期，失去手术及介入治疗机会，同时肝癌对化疗和放疗不敏感，且它们在抑制肿瘤细胞同时亦对患者的免疫功能有很...原发性肝癌（primary carcinoma of liver）是我国最常见的恶性肿瘤之一，其起病隐匿，恶性程度高，患者发病时大多已属中晚期，失去手术及介入治疗机会，同时肝癌对化疗和放疗不敏感，且它们在抑制肿瘤细胞同时亦对患者的免疫功能有很大的影响。因此，姑息治疗是目前晚期肝癌主要治疗方案。展开更多
<strong>Objectives:</strong> To study the change of CD16 + 56 in zona. <strong>Materials and Methods:</strong> 62 zona patients admitted at Inpatient Department of Dermatology, Venereology Alle...<strong>Objectives:</strong> To study the change of CD16 + 56 in zona. <strong>Materials and Methods:</strong> 62 zona patients admitted at Inpatient Department of Dermatology, Venereology Allergy, 108 Military Central Hospital, and 30 healthy volunteers who were matched for age and sex participated in this study. Prospective, cross-sectional study with controls was conducted. We measured the number of CD16 + CD56 by flow cytometry using FACS Callibur. <strong>Results:</strong> The mean level of CD16 + 56 in zona patients was 253 ± 200 (106 cells/l), which was lower than that of control group but then increased after treatment. The change of CD16 + 56 did not correlate with patients’ age. Patients who were in severe condition or had affected size from 3% or more had a lower number of CD16 + 56 than control group. <strong>Conclusion:</strong> The number of CD16 + 56 in zona patients were lower than that of healthy people.展开更多
文摘<strong>Objectives:</strong> To study the change of CD16 + 56 in zona. <strong>Materials and Methods:</strong> 62 zona patients admitted at Inpatient Department of Dermatology, Venereology Allergy, 108 Military Central Hospital, and 30 healthy volunteers who were matched for age and sex participated in this study. Prospective, cross-sectional study with controls was conducted. We measured the number of CD16 + CD56 by flow cytometry using FACS Callibur. <strong>Results:</strong> The mean level of CD16 + 56 in zona patients was 253 ± 200 (106 cells/l), which was lower than that of control group but then increased after treatment. The change of CD16 + 56 did not correlate with patients’ age. Patients who were in severe condition or had affected size from 3% or more had a lower number of CD16 + 56 than control group. <strong>Conclusion:</strong> The number of CD16 + 56 in zona patients were lower than that of healthy people.
